Cargando…

Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?

Despite the evidence that complicated rheumatic diseases are more prevalent and severe in ethnic minorities, rheumatology research is afflicted with inadequate patient representation. It is lacking in ethnic and socioeconomic diversity. The objective of this study is to identify barriers to enrollme...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhu, Vaneet K, Duro, Teodor, Kamboj, Ajay, Salto, Lorena, Chiruvolu, Neha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400834/
https://www.ncbi.nlm.nih.gov/pubmed/36039219
http://dx.doi.org/10.7759/cureus.27235
_version_ 1784772829300916224
author Sandhu, Vaneet K
Duro, Teodor
Kamboj, Ajay
Salto, Lorena
Chiruvolu, Neha
author_facet Sandhu, Vaneet K
Duro, Teodor
Kamboj, Ajay
Salto, Lorena
Chiruvolu, Neha
author_sort Sandhu, Vaneet K
collection PubMed
description Despite the evidence that complicated rheumatic diseases are more prevalent and severe in ethnic minorities, rheumatology research is afflicted with inadequate patient representation. It is lacking in ethnic and socioeconomic diversity. The objective of this study is to identify barriers to enrollment in rheumatology research and propose possible solutions to overcome these barriers. In this study, 184 patients from two rheumatology clinics (Safety Net clinic, a university-based clinic) were surveyed for concerns regarding participation in clinical research. Patients were asked to rank their top five of eight concerns. Data were then stratified by self-reported ethnicity and clinic site to determine ranking differences in both groups. Fear of risks associated with clinical research was ranked as the primary barrier in all ethnicities. More non-Hispanic Whites (NHW) (24.4%) ranked work responsibilities as a primary barrier compared to Hispanics (10%). Fear of discovering a serious illness as a primary barrier was more frequent at the Safety Net clinic (25%) compared to the university-based clinic (6.3%) and ranked more frequently in the top five in Hispanics compared to NHW. Fears associated with research risks, work responsibilities, and fear of discovering a serious illness were the top-ranked barriers to enrollment in research among patients. However, differences in rankings between ethnicities and clinic sites were identified. This sheds light on the importance of health literacy and the responsibility of researchers in addressing gaps in communication while acknowledging potential cultural components that warrant further investigation.
format Online
Article
Text
id pubmed-9400834
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-94008342022-08-28 Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why? Sandhu, Vaneet K Duro, Teodor Kamboj, Ajay Salto, Lorena Chiruvolu, Neha Cureus Rheumatology Despite the evidence that complicated rheumatic diseases are more prevalent and severe in ethnic minorities, rheumatology research is afflicted with inadequate patient representation. It is lacking in ethnic and socioeconomic diversity. The objective of this study is to identify barriers to enrollment in rheumatology research and propose possible solutions to overcome these barriers. In this study, 184 patients from two rheumatology clinics (Safety Net clinic, a university-based clinic) were surveyed for concerns regarding participation in clinical research. Patients were asked to rank their top five of eight concerns. Data were then stratified by self-reported ethnicity and clinic site to determine ranking differences in both groups. Fear of risks associated with clinical research was ranked as the primary barrier in all ethnicities. More non-Hispanic Whites (NHW) (24.4%) ranked work responsibilities as a primary barrier compared to Hispanics (10%). Fear of discovering a serious illness as a primary barrier was more frequent at the Safety Net clinic (25%) compared to the university-based clinic (6.3%) and ranked more frequently in the top five in Hispanics compared to NHW. Fears associated with research risks, work responsibilities, and fear of discovering a serious illness were the top-ranked barriers to enrollment in research among patients. However, differences in rankings between ethnicities and clinic sites were identified. This sheds light on the importance of health literacy and the responsibility of researchers in addressing gaps in communication while acknowledging potential cultural components that warrant further investigation. Cureus 2022-07-25 /pmc/articles/PMC9400834/ /pubmed/36039219 http://dx.doi.org/10.7759/cureus.27235 Text en Copyright © 2022, Sandhu et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Rheumatology
Sandhu, Vaneet K
Duro, Teodor
Kamboj, Ajay
Salto, Lorena
Chiruvolu, Neha
Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
title Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
title_full Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
title_fullStr Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
title_full_unstemmed Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
title_short Barriers to Enrollment in Rheumatology Research: Who, What, Where, When, and Why?
title_sort barriers to enrollment in rheumatology research: who, what, where, when, and why?
topic Rheumatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400834/
https://www.ncbi.nlm.nih.gov/pubmed/36039219
http://dx.doi.org/10.7759/cureus.27235
work_keys_str_mv AT sandhuvaneetk barrierstoenrollmentinrheumatologyresearchwhowhatwherewhenandwhy
AT duroteodor barrierstoenrollmentinrheumatologyresearchwhowhatwherewhenandwhy
AT kambojajay barrierstoenrollmentinrheumatologyresearchwhowhatwherewhenandwhy
AT saltolorena barrierstoenrollmentinrheumatologyresearchwhowhatwherewhenandwhy
AT chiruvoluneha barrierstoenrollmentinrheumatologyresearchwhowhatwherewhenandwhy